Share chart Alembic Pharmaceuticals Limited
Extended chart
Simple chart
About Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company provides branded specialty medicines in various therapeutic areas, such as cardiology, gynecology, gastrology, ophthalmology, dermatology, nephrology/urology, orthopedics, anti-infective, cold and cough, veterinary, and anti-diabetic; generics formulations in oral solids, oncology oral solids and injectables, general injectables and ophthalmic products, dermatology, and oral suspension; and active pharmaceutical ingredients. It also exports its products. more detailsISIN | INE901L01018 |
---|---|
Industry | Pharmaceuticals |
Sector | Health Care |
Валюта | inr |
Валюта отчета | inr |
Див.доход ао | 0.8659 |
Дивиденд ао | 11 |
Сайт | https://alembicpharmaceuticals.com |
Цена ао | 827.95 |
Change price per day: | +0.5556% (827.95) |
---|---|
Change price per week: | -1.55% (845.65) |
Change price per month: | -1.5% (845.2) |
Change price per 3 month: | -21.56% (1061.35) |
Change price per half year: | -29.58% (1182.3) |
Change price per year: | -9.27% (917.65) |
Change price per 3 year: | +15.2% (722.7) |
Change price per 5 year: | +31.84% (631.5) |
Change price per 10 year: | 0% (832.55) |
Change price per year to date: | -19.66% (1036.3) |
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
ETF | Share, % | Profitability for 1 year, % | Dividends, % |
---|---|---|---|
iShares MSCI India Small-Cap ETF | 0.15813 | 0.4625 | 0.96163 |
SPDR S&P Emerging Markets Small Cap ETF | 0.07481 | 5.46 | 3.03583 |
iShares MSCI Emerging Markets Small-Cap ETF | 0.05587 | 7.67 | 2.7853 |
![]() |
0.04848 | 5.23 | 1.65591 |
WisdomTree Emerging Markets SmallCap Dividend Fund | 0.04404 | 1.35 | 5.00999 |
![]() |
0.02 | 9.39 | 3.09932 |
Dimensional Emerging Markets Value ETF | 0.01002 | 17.07 | 4.19508 |
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund | 0.00961 | 12.46 | 3.59676 |
Dimensional Emerging Markets Core Equity 2 ETF | 0.00845 | 15.96 | 3.34087 |
Avantis Emerging Markets Equity ETF | 0.00806 | 8.77 | 3.60513 |
Dimensional World ex U.S. Core Equity 2 ETF | 0.00439 | 13.06 | 3.62488 |
SPDR Portfolio Emerging Markets ETF | 0.00394 | 11.59 | 3.1879 |
Vanguard ESG International Stock ETF | 0 | 6.39 | 3.07501 |
0.03 | 8.84 | 3.17 |
Head | Job title | Payment | Year of birth |
---|---|---|---|
Mr. Pranav Chirayu Amin | Managing Director | 122.2M | 1975 (50 years) |
Mr. Shaunak Chirayu Amin | MD & Executive Director | 122.2M | 1978 (47 years) |
Mr. Vinod Kamath | President of Operations | N/A | |
Dr. J. Venkat Raman M. S., Ph.D. | Chief Scientific Officer | N/A | 1958 (67 years) |
Ms. Manisha Saraf | Company Secretary & Compliance Officer | N/A | |
Mr. Udit C. Amin | Chief Business Development Officer | N/A | 1980 (45 years) |
Mr. Gautam Chatterjee | Senior Vice President | N/A | 1961 (64 years) |
Mr. Chirayu Ramanbhai Amin | Executive Chairman & CEO | 88M | 1946 (79 years) |
Mr. Raj Kumar Shreeram Baheti B.Com.(Hon.), FCA, FCS | Director of Finance, CFO & Executive Director | 1959 (66 years) | |
Mr. Ajay Kumar Desai | Senior Vice President of Finance |
Address: India, Vadodara, Alembic Road - open in Google maps, open in Yandex maps
Website: https://alembicpharmaceuticals.com
Website: https://alembicpharmaceuticals.com